Publicaciones en las que colabora con Ángel Pazos Carro (20)

2021

  1. 5-HT4Receptors Are Not Involved in the Effects of Fluoxetine in the Corticosterone Model of Depression

    ACS Chemical Neuroscience, Vol. 12, Núm. 11, pp. 2036-2044

2020

  1. β-Catenin Role in the Vulnerability/Resilience to Stress-Related Disorders Is Associated to Changes in the Serotonergic System

    Molecular Neurobiology, Vol. 57, Núm. 3, pp. 1704-1715

2019

  1. Targeting β-Catenin in GLAST-Expressing Cells: Impact on Anxiety and Depression-Related Behavior and Hippocampal Proliferation

    Molecular Neurobiology, Vol. 56, Núm. 1, pp. 553-566

2017

  1. Enhanced Stress Response in 5-HT1AR Overexpressing Mice: Altered HPA Function and Hippocampal Long-Term Potentiation

    ACS Chemical Neuroscience, Vol. 8, Núm. 11, pp. 2393-2401

  2. The Addiction-Related Protein ANKK1 is Differentially Expressed During the Cell Cycle in Neural Precursors

    Cerebral Cortex, Vol. 27, Núm. 5, pp. 2809-2819

2016

  1. Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: Role of 5-HT1A receptors

    Neuropharmacology, Vol. 103, pp. 16-26

  2. The absence of 5-HT4 receptors modulates depression- and anxiety-like responses and influences the response of fluoxetine in olfactory bulbectomised mice: Adaptive changes in hippocampal neuroplasticity markers and 5-HT1A autoreceptor

    Neuropharmacology, Vol. 111, pp. 47-58

  3. Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration

    Molecular Psychiatry, Vol. 21, Núm. 3, pp. 328-338

2015

  1. Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes

    Cancer Cell, Vol. 28, Núm. 2, pp. 170-182

2014

  1. Serotonin 5-HT4 receptors: A new strategy for developing fast acting antidepressants?

    Current Pharmaceutical Design, Vol. 20, Núm. 23, pp. 3751-3762

2013

  1. Neural plasticity and proliferation in the generation of antidepressant effects: Hippocampal implication

    Neural Plasticity, Vol. 2013

  2. RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis.

    Translational psychiatry, Vol. 3

  3. Reducing GABAA α5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome

    Journal of Neuroscience, Vol. 33, Núm. 9, pp. 3953-3966

  4. Region-specific regulation of 5-HT1B receptors in the rat brain by chronic venlafaxine treatment

    Psychopharmacology, Vol. 229, Núm. 1, pp. 177-185

2012

  1. Modulation of neuroplasticity pathways and antidepressant-like behavioural responses following the short-term (3 and 7 days) administration of the 5-HT 4 receptor agonist RS67333

    International Journal of Neuropsychopharmacology, Vol. 15, Núm. 5, pp. 631-643

  2. Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, β-catenin and antidepressant-like effects

    British Journal of Pharmacology, Vol. 165, Núm. 4 B, pp. 1046-1057

2011

  1. New strategies in the development of antidepressants: Towards the modulation of neuroplasticity pathways

    Current Pharmaceutical Design, Vol. 17, Núm. 5, pp. 521-533

2010

  1. Long-term fluoxetine treatment modulates cannabinoid type 1 receptor-mediated inhibition of adenylyl cyclase in the rat prefrontal cortex through 5-hydroxytryptamine1A receptor-dependent mechanisms

    Molecular Pharmacology, Vol. 77, Núm. 3, pp. 424-434

  2. Reduced signal transduction by 5-HT 4 receptors after long-term venlafaxine treatment in rats

    British Journal of Pharmacology, Vol. 161, Núm. 3, pp. 695-706

2009

  1. Long-term treatment with fluoxetine induces desensitization of 5-HT 4 receptor-dependent signalling and functionality in rat brain

    Journal of Neurochemistry, Vol. 110, Núm. 3, pp. 1120-1127